Changes to This Summary (05/30/2013)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Multiple Endocrine Neoplasia Type 1 (MEN1)

Added Figure 1, MEN1 Pedigree.

Revised Table 2, Practice Guidelines for Surveillance of MEN1, to state that duodenopancreatic gastrinoma is screened using a fasting serum gastrin biochemical test and that insulinomas are screened using fasting glucose and insulin biochemical tests.

Multiple Endocrine Neoplasia Type 2

Added National Comprehensive Cancer Network as reference 24.

Added Figure 2, Multiple Endocrine Neoplasia Type 2A Pedigree.

Familial Paraganglioma Syndrome

Added this new section.

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.